Clinical Research Directory

Inclusion Criteria: * Participants who meet the diagnostic criteria for coronary heart disease * Participants who underwent successful percutaneous coronary intervention * Participants aged between 18 and 80 * Participants of any gender * Participants who have signed an informed consent form Exclusion Criteria: * Subjects with severe hepatic or renal impairment * subjects with severe electrolyte disturbances * subjects with severe haematological disorders or malignant tumours * pregnant or breastfeeding women * subjects with psychiatric disorders * subjects with cognitive impairment (e.g. dementia, post-stroke cognitive impairment) that prevents them from understanding or carrying out exercise instructions * Subjects scheduled to undergo repeat revascularisation surgery in the near future * Subjects with other severe cardiovascular diseases such as uncontrolled hypertension, angina pectoris, rapid arrhythmias, high-degree or complete atrioventricular block (without a pacemaker), acute severe aortic stenosis, decompensated heart failure (NYHA Class IV), deep vein thrombosis, obstructive hypertrophic cardiomyopathy, acute pericarditis or myocarditis, acute endocarditis, or acute aortic dissection * Participants with acute pulmonary embolism or chronic lung disease accompanied by symptoms of dyspnoea (occurring at rest or with minimal exertion) * Subjects with impaired limb mobility or who are unable to move independently; * Subjects with Shy-Drager syndrome * Subjects who have participated in a clinical trial involving other drugs or exercise interventions within the past month * Subjects deemed by the investigator to have other conditions rendering them unsuitable for participation in the trial